411 related articles for article (PubMed ID: 18406489)
1. Molecular interactions, internal structure and drug release kinetics of rationally developed polymer-lipid hybrid nanoparticles.
Li Y; Wong HL; Shuhendler AJ; Rauth AM; Wu XY
J Control Release; 2008 May; 128(1):60-70. PubMed ID: 18406489
[TBL] [Abstract][Full Text] [Related]
2. Screening of lipid carriers and characterization of drug-polymer-lipid interactions for the rational design of polymer-lipid hybrid nanoparticles (PLN).
Li Y; Taulier N; Rauth AM; Wu XY
Pharm Res; 2006 Aug; 23(8):1877-87. PubMed ID: 16850265
[TBL] [Abstract][Full Text] [Related]
3. Engineering of a hybrid polymer-lipid nanocarrier for the nasal delivery of tenofovir disoproxil fumarate: physicochemical, molecular, microstructural, and stability evaluation.
Pokharkar VB; Jolly MR; Kumbhar DD
Eur J Pharm Sci; 2015 Apr; 71():99-111. PubMed ID: 25708940
[TBL] [Abstract][Full Text] [Related]
4. Solid lipid nanoparticles loaded with insulin by sodium cholate-phosphatidylcholine-based mixed micelles: preparation and characterization.
Liu J; Gong T; Wang C; Zhong Z; Zhang Z
Int J Pharm; 2007 Aug; 340(1-2):153-62. PubMed ID: 17428627
[TBL] [Abstract][Full Text] [Related]
5. Magnetic drug-targeting carrier encapsulated with thermosensitive smart polymer: core-shell nanoparticle carrier and drug release response.
Zhang J; Misra RD
Acta Biomater; 2007 Nov; 3(6):838-50. PubMed ID: 17638599
[TBL] [Abstract][Full Text] [Related]
6. Design and characterization of a new drug nanocarrier made from solid-liquid lipid mixtures.
Garcia-Fuentes M; Alonso MJ; Torres D
J Colloid Interface Sci; 2005 May; 285(2):590-8. PubMed ID: 15837476
[TBL] [Abstract][Full Text] [Related]
7. Simultaneous delivery of doxorubicin and GG918 (Elacridar) by new polymer-lipid hybrid nanoparticles (PLN) for enhanced treatment of multidrug-resistant breast cancer.
Wong HL; Bendayan R; Rauth AM; Wu XY
J Control Release; 2006 Dec; 116(3):275-84. PubMed ID: 17097178
[TBL] [Abstract][Full Text] [Related]
8. Preparation and characterization of Paliperidone loaded solid lipid nanoparticles.
Kumar S; Randhawa JK
Colloids Surf B Biointerfaces; 2013 Feb; 102():562-8. PubMed ID: 23104026
[TBL] [Abstract][Full Text] [Related]
9. In vitro characterization and invivo toxicity study of repaglinide loaded poly (methyl methacrylate) nanoparticles.
Dhana Lekshmi UM; Poovi G; Kishore N; Reddy PN
Int J Pharm; 2010 Aug; 396(1-2):194-203. PubMed ID: 20600729
[TBL] [Abstract][Full Text] [Related]
10. Non-destructive methods of characterization of risperidone solid lipid nanoparticles.
Rahman Z; Zidan AS; Khan MA
Eur J Pharm Biopharm; 2010 Sep; 76(1):127-37. PubMed ID: 20470882
[TBL] [Abstract][Full Text] [Related]
11. Enhancement in antifungal activity of eugenol in immunosuppressed rats through lipid nanocarriers.
Garg A; Singh S
Colloids Surf B Biointerfaces; 2011 Oct; 87(2):280-8. PubMed ID: 21689909
[TBL] [Abstract][Full Text] [Related]
12. In vivo evaluation of a new polymer-lipid hybrid nanoparticle (PLN) formulation of doxorubicin in a murine solid tumor model.
Wong HL; Rauth AM; Bendayan R; Wu XY
Eur J Pharm Biopharm; 2007 Mar; 65(3):300-8. PubMed ID: 17156986
[TBL] [Abstract][Full Text] [Related]
13. Optimization of controlled release nanoparticle formulation of verapamil hydrochloride using artificial neural networks with genetic algorithm and response surface methodology.
Li Y; Abbaspour MR; Grootendorst PV; Rauth AM; Wu XY
Eur J Pharm Biopharm; 2015 Aug; 94():170-9. PubMed ID: 25986587
[TBL] [Abstract][Full Text] [Related]
14. Investigation of the release mechanism of a sparingly water-soluble drug from solid dispersions in hydrophilic carriers based on physical state of drug, particle size distribution and drug-polymer interactions.
Karavas E; Georgarakis E; Sigalas MP; Avgoustakis K; Bikiaris D
Eur J Pharm Biopharm; 2007 Jun; 66(3):334-47. PubMed ID: 17267194
[TBL] [Abstract][Full Text] [Related]
15. A Novel Polymer-Lipid Hybrid Nanoparticle for the Improvement of Topotecan Hydrochloride Physicochemical Properties.
Silva EJ; Souza LG; Silva LAD; Taveira SF; Guilger RC; Liao LM; Queiroz Junior LHK; Santana MJ; Marreto RN
Curr Drug Deliv; 2018; 15(7):979-986. PubMed ID: 29243576
[TBL] [Abstract][Full Text] [Related]
16. Poly(vinyl alcohol) as emulsifier stabilizes solid triglyceride drug carrier nanoparticles in the alpha-modification.
Rosenblatt KM; Bunjes H
Mol Pharm; 2009; 6(1):105-20. PubMed ID: 19049318
[TBL] [Abstract][Full Text] [Related]
17. Magnetically guided release of ciprofloxacin from superparamagnetic polymer nanocomposites.
Gupta R; Bajpai AK
J Biomater Sci Polym Ed; 2011; 22(7):893-918. PubMed ID: 20566063
[TBL] [Abstract][Full Text] [Related]
18. Pullulan acetate nanoparticles prepared by solvent diffusion method for epirubicin chemotherapy.
Zhang HZ; Gao FP; Liu LR; Li XM; Zhou ZM; Yang XD; Zhang QQ
Colloids Surf B Biointerfaces; 2009 Jun; 71(1):19-26. PubMed ID: 19186037
[TBL] [Abstract][Full Text] [Related]
19. Dissolution rate enhancement of the poorly water-soluble drug Tibolone using PVP, SiO2, and their nanocomposites as appropriate drug carriers.
Papadimitriou S; Bikiaris D
Drug Dev Ind Pharm; 2009 Sep; 35(9):1128-38. PubMed ID: 19555245
[TBL] [Abstract][Full Text] [Related]
20. Aqueous microgels for the growth of hydroxyapatite nanocrystals.
Schachschal S; Pich A; Adler HJ
Langmuir; 2008 May; 24(9):5129-34. PubMed ID: 18363417
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
